• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 05168589190
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/14/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).(b)(4).
 
Event Description
The customer complained of erroneous results for 1 patient tested for crep2 creatinine plus ver.2 (crep2) on a cobas 8000 c 702 module.The erroneous results were not reported outside of the laboratory.On (b)(6) 2017 the patient was tested 3 times on different blood collections with crep2 results of 151 umol/l, 130 umol/l and 127 umol/l.On (b)(6) 2017 the patient was tested and the crep2 result was < 3 umol/l.A 1:10 dilution was performed and the result was 87 umol/l.On (b)(6) 2017 a new sample was obtained and the initial crep2 result was < 3 umol/l.A 1:2 dilution was performed and the result was < 3 umol/l.A 1:10 dilution was performed and the result was 120 umol/l.The sample was sent to another laboratory using an integra system with the creatinine jaffe method and the result was 68 umol/l.The patient is on various drugs that are common among many patients.The patient is on carbocisteine.The customer thinks carbocisteine may interfere with the results produced by the crep2 assay.There was no allegation that an adverse event occurred.The c702 module serial number was (b)(4).
 
Manufacturer Narrative
It was clarified that the result of 156 umol/l was from a 1:10 onboard dilution and was from the same sample.The result of 156 umol/l was not reported outside of the laboratory as it did not fit the patient's history.The customer did report a result of 64 umol/l from the creatinine jaffe method.The customer performed an interference analysis of the patient sample and found that the patient has a large igm kappa paraprotein.This interference is addressed in the product labeling for the assay.Product labeling states "in very rare cases, gammopathy, in particular type igm (waldenström¿s macroglobulinemia), may cause unreliable results.".
 
Manufacturer Narrative
It is currently not known when the patient was started on carbocisteine.The patient was taking 750 mg three times per day.The clinicians have stopped the carbocisteine treatment, but, recent blood test results seem to be the same.On (b)(6) 2017 the patient was tested for crea2 3 times with results of (-) 132 with a data flag (unit of measure not provided), (-) 102 with a data flag and 156.It is not known if these results are from the same sample or different blood collections.It is also not known if these results were obtained after carbocisteine was stopped.This information has been requested.The customer mentioned they have 1 other patient being treated with carbocisteine and there are no issues with the enzymatic creatinine results for that patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6903697
MDR Text Key89495820
Report Number1823260-2017-02148
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K024098
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup
Report Date 11/14/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05168589190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/12/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age67 YR
-
-